Skip to main content

Table 5 Relationship between tumor absorbed dose and tumor response

From: Safety and efficacy of Y-90 microsphere treatment in patients with primary and metastatic liver cancer: The tumor selectivity of the treatment as a function of tumor to liver flow ratio

Tumor response Patients Tumor dose (Gy)
   Average Median
Responders 27 120.3 107.8
Non-responders 13 123.9 76.9